
Resilience, Reinvention, and Revolution: Persian Entrepreneur Maky Zanganeh’s Journey from Cancer Survivor to Pharma Billionaire
Maky Zanganeh, Persian entrepreneur and cancer survivor, transformed from dentistry and robotic surgery to biotech leadership. Fleeing Iran’s revolution, she invested in Pharmacyclics in 2004, rising to COO and driving Imbruvica’s blockbuster success, culminating in AbbVie’s $21 billion acquisition. As Summit Therapeutics Co-CEO, her ivonescimab bet propelled shares 17-fold, minting her billionaire status amid oncology innovation.




